ATAZANAVIR - ORAL
Common Brand Name(s): Reyataz
Phonetic Pronunciation: (ah-tah-ZAN-ah-veer)
Information last revised June 2010
What does ATAZANAVIR - ORAL look like?
Reyataz 100 mg Cap
Reyataz 150 mg Cap
Reyataz 200 mg Cap
Reyataz 300 mg Cap
This drug is used in combination with other medications to help control your HIV infection, thereby improving your quality of life. It also lowers your risk of getting HIV disease complications (e.g., new infections, cancer). Atazanavir belongs to a class of drugs known as protease inhibitors. Atazanavir is not a cure for HIV infection, and it does not prevent the spread of HIV to others through sexual contact or blood contamination (e.g., sharing used needles).
This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
The information contained in the First DataBank databases is intended to supplement the knowledge of physicians, pharmacists, and other healthcare professionals regarding drug therapy problems and patient counselling information. This information is advisory only and is not intended to replace sound clinical judgment in the delivery of healthcare services. First DataBank disclaims all warranties, whether expressed or implied, including any warranty as to the quality, accuracy, and suitability of this information for any purpose.
Copyright 2010 First DataBank, Inc.